Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models

The human photoreceptor function is dependent on a highly specialised cilium. Perturbation of cilial function can often lead to death of the photoreceptor and loss of vision. Retinal ciliopathies are a genetically diverse range of inherited retinal disorders affecting aspects of the photoreceptor ci...

Full description

Bibliographic Details
Main Authors: Andrew McDonald, Jan Wijnholds
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/5/2887
_version_ 1797264342427631616
author Andrew McDonald
Jan Wijnholds
author_facet Andrew McDonald
Jan Wijnholds
author_sort Andrew McDonald
collection DOAJ
description The human photoreceptor function is dependent on a highly specialised cilium. Perturbation of cilial function can often lead to death of the photoreceptor and loss of vision. Retinal ciliopathies are a genetically diverse range of inherited retinal disorders affecting aspects of the photoreceptor cilium. Despite advances in the understanding of retinal ciliopathies utilising animal disease models, they can often lack the ability to accurately mimic the observed patient phenotype, possibly due to structural and functional deviations from the human retina. Human-induced pluripotent stem cells (hiPSCs) can be utilised to generate an alternative disease model, the 3D retinal organoid, which contains all major retinal cell types including photoreceptors complete with cilial structures. These retinal organoids facilitate the study of disease mechanisms and potential therapies in a human-derived system. Three-dimensional retinal organoids are still a developing technology, and despite impressive progress, several limitations remain. This review will discuss the state of hiPSC-derived retinal organoid technology for accurately modelling prominent retinal ciliopathies related to genes, including <i>RPGR</i>, <i>CEP290</i>, <i>MYO7A</i>, and <i>USH2A</i>. Additionally, we will discuss the development of novel gene therapy approaches targeting retinal ciliopathies, including the delivery of large genes and gene-editing techniques.
first_indexed 2024-04-25T00:27:23Z
format Article
id doaj.art-145e863f94a74ec88791ff6b67ee6fa8
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-25T00:27:23Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-145e863f94a74ec88791ff6b67ee6fa82024-03-12T16:46:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-03-01255288710.3390/ijms25052887Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid ModelsAndrew McDonald0Jan Wijnholds1Department of Ophthalmology, Leiden University Medical Center (LUMC), 2333 ZC Leiden, The NetherlandsDepartment of Ophthalmology, Leiden University Medical Center (LUMC), 2333 ZC Leiden, The NetherlandsThe human photoreceptor function is dependent on a highly specialised cilium. Perturbation of cilial function can often lead to death of the photoreceptor and loss of vision. Retinal ciliopathies are a genetically diverse range of inherited retinal disorders affecting aspects of the photoreceptor cilium. Despite advances in the understanding of retinal ciliopathies utilising animal disease models, they can often lack the ability to accurately mimic the observed patient phenotype, possibly due to structural and functional deviations from the human retina. Human-induced pluripotent stem cells (hiPSCs) can be utilised to generate an alternative disease model, the 3D retinal organoid, which contains all major retinal cell types including photoreceptors complete with cilial structures. These retinal organoids facilitate the study of disease mechanisms and potential therapies in a human-derived system. Three-dimensional retinal organoids are still a developing technology, and despite impressive progress, several limitations remain. This review will discuss the state of hiPSC-derived retinal organoid technology for accurately modelling prominent retinal ciliopathies related to genes, including <i>RPGR</i>, <i>CEP290</i>, <i>MYO7A</i>, and <i>USH2A</i>. Additionally, we will discuss the development of novel gene therapy approaches targeting retinal ciliopathies, including the delivery of large genes and gene-editing techniques.https://www.mdpi.com/1422-0067/25/5/2887retinal ciliopathyretinal organoidciliumgene therapyCRISPR/Cas9adeno-associated virus (AAV)
spellingShingle Andrew McDonald
Jan Wijnholds
Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
International Journal of Molecular Sciences
retinal ciliopathy
retinal organoid
cilium
gene therapy
CRISPR/Cas9
adeno-associated virus (AAV)
title Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
title_full Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
title_fullStr Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
title_full_unstemmed Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
title_short Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
title_sort retinal ciliopathies and potential gene therapies a focus on human ipsc derived organoid models
topic retinal ciliopathy
retinal organoid
cilium
gene therapy
CRISPR/Cas9
adeno-associated virus (AAV)
url https://www.mdpi.com/1422-0067/25/5/2887
work_keys_str_mv AT andrewmcdonald retinalciliopathiesandpotentialgenetherapiesafocusonhumanipscderivedorganoidmodels
AT janwijnholds retinalciliopathiesandpotentialgenetherapiesafocusonhumanipscderivedorganoidmodels